Technical Analysis for BNTX - BioNTech SE
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
20 DMA Support | Bullish | 0.55% | |
Calm After Storm | Range Contraction | 0.55% | |
Down 3 Days in a Row | Weakness | 0.55% | |
Down 4 Days in a Row | Weakness | 0.55% | |
Gapped Down | Weakness | 0.55% | |
Calm After Storm | Range Contraction | 0.09% | |
Upper Bollinger Band Walk | Strength | 0.09% | |
Down 3 Days in a Row | Weakness | 0.09% |
Alert | Time |
---|---|
10 DMA Support | about 19 hours ago |
Rose Above Previous Day's High | about 19 hours ago |
Rose Above 10 DMA | about 19 hours ago |
Up 1% | about 19 hours ago |
20 DMA Support | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/20/2024
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Biomarkers Allergy Autoimmunity In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Biomarkers Allergy Autoimmunity In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 136.915 |
52 Week Low | 87.9001 |
Average Volume | 609,178 |
200-Day Moving Average | 103.57 |
50-Day Moving Average | 95.63 |
20-Day Moving Average | 92.35 |
10-Day Moving Average | 92.86 |
Average True Range | 2.52 |
RSI (14) | 48.98 |
ADX | 16.2 |
+DI | 24.43 |
-DI | 21.34 |
Chandelier Exit (Long, 3 ATRs) | 89.94 |
Chandelier Exit (Short, 3 ATRs) | 95.46 |
Upper Bollinger Bands | 96.04 |
Lower Bollinger Band | 88.67 |
Percent B (%b) | 0.59 |
BandWidth | 7.99 |
MACD Line | -0.43 |
MACD Signal Line | -0.86 |
MACD Histogram | 0.4323 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 96.54 | ||||
Resistance 3 (R3) | 96.49 | 95.25 | 95.95 | ||
Resistance 2 (R2) | 95.25 | 94.35 | 95.28 | 95.75 | |
Resistance 1 (R1) | 94.12 | 93.79 | 94.69 | 94.17 | 95.55 |
Pivot Point | 92.89 | 92.89 | 93.17 | 92.91 | 92.89 |
Support 1 (S1) | 91.76 | 91.98 | 92.32 | 91.81 | 90.43 |
Support 2 (S2) | 90.52 | 91.42 | 90.55 | 90.23 | |
Support 3 (S3) | 89.39 | 90.52 | 90.03 | ||
Support 4 (S4) | 89.44 |